Kaleido Biosciences Inc

NASDAQ:KLDO   3:59:54 PM EDT
5.63
+0.09 (+1.62%)
Products

Kaleido Biosciences Received Warning Letter From U.S. FDA

Published: 09/03/2021 20:41 GMT
Kaleido Biosciences Inc (KLDO) - Kaleido Biosciences - on Aug.
27, Received Warning Letter From U.S. FDA for Failure to Submit Ind Prior to Conducting Two Studies in Subjects With Covid-19.
Kaleido Biosciences - Coordinating With FDA and Intends to Continue With Its Plans to Submit an Ind for Kb109 in Support of Future Clinical Research.
Kaleido Biosciences, on FDA Warning Letter, Says There Were No Findings Related to Conduct Or Oversight of Two Studies in Subjects With Covid-19.
Kaleido Biosciences, on FDA Warning Letter, Says There Were No Findings Related to Data That Was Generated From 2 Studies in Subjects With Covid-19.